Immunologic Markers as Predictors of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in HIV and Tuberculosis Coinfected Persons in Thailand
- 1 November 2009
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 25 (11) , 1083-1089
Abstract
This study analyzes immunologic markers to predict and diagnose tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in HIV and TB coinfected adults who initiated antiretroviral therapy (ART) in Thailand. T helper 1 cytokines interleukin (IL)-2, IL-12, and interferon-gamma (IFN-γ) levels in response to PPD and RD1 antigens were assessed prior to ART, at weeks 6, 12, and 24 of treatment, and at time of TB-IRIS. Of 126 subjects, 22 (17.5%) developed TB-IRIS; 14 (64%) subjects received steroid treatment and 3 (14%) received NSAIDs; none of the subjects died. Median interval between ART initiation and TB-IRIS development was 14 days. IFN-γ, IL-2, and IL-12 responses did not differ between TB-IRIS and no TB-IRIS subjects (p > 0.05). More research into the immunopathogenesis of TB-IRIS and diagnostic potential of cytokine markers is warranted.Keywords
This publication has 27 references indexed in Scilit:
- A Randomized Trial Comparing Plasma Drug Concentrations and Efficacies between 2 Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Regimens in HIV‐Infected Patients Receiving Rifampicin: The N2R StudyClinical Infectious Diseases, 2009
- Type 1 Helper T Cells and FoxP3-positive T Cells in HIV–Tuberculosis-associated Immune Reconstitution Inflammatory SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2008
- HIV-Associated Tuberculosis: Diagnostic and Treatment ChallengesSeminars in Respiratory and Critical Care Medicine, 2008
- Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settingsThe Lancet Infectious Diseases, 2008
- Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration diseaseAIDS Research and Therapy, 2008
- Immune Reconstitution and “Unmasking” of Tuberculosis during Antiretroviral TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients Receiving Antiretroviral TherapyDrugs, 2008
- Immune reconstitution disease: recent developments and implications for antiretroviral treatment in resource-limited settingsCurrent Opinion in HIV and AIDS, 2007
- Determinants of Immune Reconstitution Inflammatory Syndrome in HIV Type 1–Infected Patients with Tuberculosis after Initiation of Antiretroviral TherapyClinical Infectious Diseases, 2004
- Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responsesJournal of Allergy and Clinical Immunology, 2000